Ligand profile
SGV
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01981 — Chaperone protein dnaK
Identifiers
Database identifiers and provenance.
- Ligand ID
SGV- PDB
5aqz- UniProt (similar protein)
P0DMV8- Target protein
- KP13_01981
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 169.7
- −1 ≤ LogP ≤ 5 -2.28
- MW ≤ 500 Da 309.3
- LogP ≤ 5 -2.28
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 169.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1c(c2c(ncnc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)Nc1c(c2c(ncnc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)N
InChI=1S/C12H15N5O5/c13-9-6-4(10(14)21)1-17(11(6)16-3-15-9)12-8(20)7(19)5(2-18)22-12/h1,3,5,7-8,12,18-20H,2H2,(H2,14,21)(H2,13,15,16)/t5-,7-,8-,12-/m1/s1InChI=1S/C12H15N5O5/c13-9-6-4(10(14)21)1-17(11(6)16-3-15-9)12-8(20)7(19)5(2-18)22-12/h1,3,5,7-8,12,18-20H,2H2,(H2,14,21)(H2,13,15,16)/t5-,7-,8-,12-/m1/s1
OBZJZDHRXBKKTJ-JTFADIMSSA-NOBZJZDHRXBKKTJ-JTFADIMSSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00012
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand SGV →
- PDB RCSB structure 5aqz →
- UniProt UniProt P0DMV8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “SGV”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01981.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).